Mineralocorticoid excess and inhibition of 11 β‐hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome
- 1 December 1992
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 37 (6), 483-492
- https://doi.org/10.1111/j.1365-2265.1992.tb01478.x
Abstract
OBJECTIVE 11 β-Hydroxysteroid dehydrogenase protects renal mineralocorticoid receptors from Cortisol by converting Cortisol to inactive cortisone. We hypothesize that 11 β-dehydrogenase is inhibited by ACTH, providing a mechanism whereby Cortisol induces hypokalemic alkalosis in ectopic ACTH syndrome. DESIGN/MEASUREMENTS The principal sources of plasma cortisone were assessed by selective venous catheterization with measurement of Cortisol and cortisone by radioimmunoassays. The effect of ACTH on peripheral plasma cortisol/cortisone ratio was assessed in healthy volunteers during circadian rhythm, insulin induced hypoglycaemia, and infusions with exogenous ACTH or Cortisol. In patients with Cushing's syndrome plasma cortisol/cortisone ratios were related to plasma potassium, corticosterone, and 11-deoxycorticosterone concentrations. PATIENTS Catheterization was performed in 24 patients with valvular or ischaemic heart disease. Cushing's syndrome patients included: 15 with pituitary adenoma; two with adrenal adenoma; and nine with ectopic ACTH secretion. RESULTS Plasma cortisol/cortisone ratios were low in renal vein and high in hepatic vein. In healthy volunteers plasma cortisone increased during Cortisol infusion but did not change with increases in endogenous or exogenous ACTH. Plasma cortisol/cortisone ratios were higher in ectopic ACTH syndrome than in other forms of Cushing's syndrome. However, the cortisol/cortisone ratio was no better a predictor of hypokalaemia than the levels of 11-deoxycorticosterone or corticosterone. CONCLUSIONS Peripheral conversion of Cortisol to cortisone occurs mainly in the kidney and is inhibited by ACTH. In ectopic ACTH syndrome the characteristic mineralocorticoid excess can be accounted for by a combination of increased secretion of Cortisol, corticosterone and of 11-deoxycorticosterone and decreased inactivation of Cortisol and corticosterone by 11 β-dehydrogenase.Keywords
This publication has 40 references indexed in Scilit:
- 11β‐Hydroxysteroid dehydrogenase and enzyme‐mediated receptor protection: Life after liquorice?Clinical Endocrinology, 1991
- THE KIDNEY IS THE MAJOR SITE OF CORTISONE PRODUCTION IN MANClinical Endocrinology, 1989
- Understanding the mechanism of adrenocortical steroid hypertensionJournal of Steroid Biochemistry, 1989
- HYPERMINERALOCORTICISM WITHOUT ELEVATION OF PLASMA ALDOSTERONE: DEOXYCORTICOSTERONE‐PRODUCING ADRENAL ADENOMA AND HYPERPLASIAClinical Endocrinology, 1988
- 11β-Hydroxysteroid dehydrogenase: Fact or fancy?Steroids, 1984
- INVESTIGATION OF URINARY STEROID PROFILES AS A DIAGNOSTIC METHOD IN CUSHING'S SYNDROMEClinical Endocrinology, 1982
- Mineralocorticoid production in hyperadrenocorticism: Role in pathogenesis of hypokalemic alkalosisThe American Journal of Medicine, 1971
- Parotid fluid cortisol and cortisoneJournal of Clinical Investigation, 1969
- STUDIES IN CUSHING'S SYNDROME. III. URINARY 17-KETOSTEROIDS IN PATIENTS WITH BILATERAL ADRENAL CORTICAL HYPERPLASIA*Journal of Clinical Investigation, 1959
- Quantitative Determination of the Urinary Cortisolc Metabolites, “Tetrahydro F,” “Allo-Tetrahydro F” and “Tetrahydro E”: Effects of Adrenocorticotropin and Complex Trauma in the Human1Journal of Clinical Investigation, 1958